# Remyelination in Multiple Sclerosis: a PET-MR Longitudinal Study Investigating Individual Profiles of Myelin Repair and the Contribution of Neuroinflammation

> **NCT05147532** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 80 (estimated)

## Conditions studied

- Multiple Sclerosis
- Inflammatory Disease

## Interventions

- **PROCEDURE:** PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714

## Key facts

- **NCT ID:** NCT05147532
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-24
- **Primary completion:** 2023-10
- **Final completion:** 2024-05
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05147532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05147532, "Remyelination in Multiple Sclerosis: a PET-MR Longitudinal Study Investigating Individual Profiles of Myelin Repair and the Contribution of Neuroinflammation". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05147532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*